Prolonged Photobiomodulation with Deep Red Light Mitigates Incipient Retinal Deterioration in a Mouse Model of Type 2 Diabetes
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212128 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gabriela Opazo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro Interdisciplinario de Neurociencia de Valparaíso, Universidad de Valparaíso, Valparaíso 2360102, Chile. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Retinopathy, Low-Level Light Therapy, Electroretinography. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, ANID-FONDECYT.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic retinopathy is a prevalent complication of type 2 diabetes mellitus, characterized by progressive damage to the retinal structure and function. Photobiomodulation therapy, using red or near-infrared light, has been proposed as a non-invasive intervention to mitigate retinal damage, but has been tested generally with short-term stimuli. This study aimed to evaluate the effects of prolonged photobiomodulation with deep red light on retinal structure and function in a type 2 diabetes mouse model. Transgenic LepRdb/J (db/db) mice were exposed to photobiomodulation therapy via LED devices emitting 654 nm light for 12 h daily over ten weeks and compared to untreated mice. Retinal function was evaluated by flash electroretinography, while structural changes were assessed through histology and immunohistochemistry to detect astro- and microgliosis. At 33 weeks of age, db/db mice were obese and severely diabetic, but exhibited only incipient indicators of retinal deterioration. Electroretinogram b-wave peak latencies were prolonged at intermediate flash intensities, while the outer plexiform layer displayed significantly elevated IBA1 expression. Photobiomodulation therapy prevented these two markers of early retinal deterioration but had no effect on other morphological and functional parameters. Photobiomodulation is well-tolerated and maintains potential as a complementary treatment option for diabetic retinopathy but requires further optimization of therapeutic settings and combinatory treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro Interdisciplinario de Neurociencia de Valparaíso, Universidad de Valparaíso, Valparaíso 2360102, Chile.
- Instituto de Biología, Facultad de Ciencias, Universidad de Valparaíso, Valparaíso 2360102, Chile.
ORCID-Profile: Gabriela Opazo, Felipe Tapia, Alex H Vielma, Oliver Schmachtenberg
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
- ANID-FONDECYT
Zitieren
APA
Opazo, G., Tapia, F., Díaz, A., Vielma, A. H., & Schmachtenberg, O. (2024). Prolonged Photobiomodulation with Deep Red Light Mitigates Incipient Retinal Deterioration in a Mouse Model of Type 2 Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212128
Vancouver
Opazo G, Tapia F, Díaz A, Vielma AH, Schmachtenberg O. Prolonged Photobiomodulation with Deep Red Light Mitigates Incipient Retinal Deterioration in a Mouse Model of Type 2 Diabetes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212128
BibTeX
@article{Opazo2024,
author = {Opazo, Gabriela and Tapia, Felipe and Díaz, Alejandra and Vielma, Alex H and Schmachtenberg, Oliver},
title = {Prolonged Photobiomodulation with Deep Red Light Mitigates Incipient Retinal Deterioration in a Mouse Model of Type 2 Diabetes},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212128}
}
EUVIMED